ArticleFrontiers in immunology2026

Immune checkpoint crosstalk: CTLA-4/CD80 engagement as a predictor of anti-PD-1/PD-L1 therapy outcome in NSCLC.

Juan Gumuzio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.